Gottlieb Is Nominee for FDA Commissioner
President Donald Trump announced (here) that he plans to nominate Scott Gottlieb to serve as Food and Drug Administration (FDA) commissioner. Gottlieb is a physician, a resident fellow at the American Enterprise Institute, a venture partner at venture capital firm…
Sign up for a free preview to unlock the rest of this article
If your job depends on informed compliance, you need International Trade Today. Delivered every business day and available any time online, only International Trade Today helps you stay current on the increasingly complex international trade regulatory environment.
New Enterprise Associates, and a clinical professor at New York University School of Medicine. Gottlieb was the FDA’s deputy commissioner for medical and scientific affairs from 2005 to 2007. The Senate Health, Education, Labor and Pensions Committee will consider Gottlieb’s nomination. Committee ranking member Patty Murray, D-Wash., in a statement (here) said she will closely evaluate Gottlieb on his approach to food safety, youth tobacco use prevention, and encouraging markets for generic and biosimilar drugs, among other things. Committee Chairman Lamar Alexander, R-Tenn., in a statement (here) lauded Gottlieb’s qualifications as a physician and former FDA official.